PolyNovo UK Ltd officially launch its NovoSorb® BTM synthetic dermal scaffold at MEDICA 2021 in November. Background Surgical and traumatic … continue reading “NovoSorb® BTM Synthetic Wound Matrix Launches at MEDICA”
New tissue expander with smooth surface aids insertion and removal in breast reconstruction surgery
New publication adds to substantial supportive clinical data in primary and revision augmentation and reconstruction patients
RTI will now offer a more pliable version of its Fortiva Tissue Matrix
Newly cleared minimally invasive device for lateral cartilage support in patients with nasal valve collapse, a major cause of nasal obstruction
Seems patients like AeroForm, a novel, patient-controlled method of tissue expansion prior to breast reconstruction surgery
Two new clearances have been announced for technologies to treat a variety of aesthetic treatments
The most technologically advanced prosthetic hand in the world is changing the life of a 30 year amputee
Less than 18 months since submitting the first part of a modular PMA, the VenaSeal varicose vein treatment system has now gained FDA PMA approval
Intact Medical Corporation’s marketing clearance sees it usable for remove intact breast lesions up to 30mm in diameter.
Allergan, Inc. has announced that it has received approval from the U.S. FDA to market two new styles, X and L, of the Natrelle® 410 Highly Cohesive Anatomically Shaped Silicone-Filled Breast Implants for use in breast reconstruction, augmentation and revision surgery.
Two technologies that promise a lot in burns treatment and wound care respectively need more evidence before UK’s NICE will support their adoption.
BioTime, Inc. says its Premvia™ hydrogel tissue substitute has been cleared for marketing as a Class II medical device.
Cynosure, Inc., has received FDA 510(k) clearance for its flagship PicoSure Picosecond Laser Workstation for the treatment of acne scars.
Kinetic Concepts, Inc. has announced the EU launch of its CelluTome™ Epidermal Harvesting System, delivering an automated, precise and reproducible process of harvesting autologous epidermal tissue for grafting.
The U.S. FDA has cleared for marketing the DEKA Arm System, the first prosthetic arm that can perform multiple, simultaneous powered movements controlled by electrical signals from electromyogram (EMG) electrodes.